on 25 Apr 2023
Last Applicant/ Owned by
F-78550 HOUDAN
FR
Serial Number
79320342 filed on 20th May 2021
Registration Number
7033011 registered on 25th Apr 2023
Correspondent Address
Duane M. Byers
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Medical and pharmaceutical research and development in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; scientific research and development; bacteriological scientific research Read More
Medical and pharmaceutical research and development in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; scientific research and development; bacteriological scientific research and consultation; provision of information and data relating to medical and veterinary research and development; provision of scientific and technological information in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; design and development of pharmaceuticals, nutritional supplements and dietetic supplements comprising living and inactivated microorganisms; research and development of formulations, namely, pharmaceuticals, nutritional supplements, and dietary supplements for the administration of heat-treated Lactobacillus strains combined with their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; research and development of pharmaceutical ingredients based on enriched culture medium and heat-treated bacteria, namely, Lactobacillus strains; research and development of formulations, namely, pharmaceutials, nutritional supplements, and dietetic supplements, based on enriched culture medium and heat-treated micro-organisms; technological consultation in the field of bacteria-based ingredients and in the field of postbiotics
N/A
N/A
Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, autisms, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, obsessive-compulsive disorders, addiction, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, necrotizing enterocolitis, enteritis, skin inflammation, and skin infections, and veterinary pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, enteritis, skin inflammation, and skin infections; dietetic foods adapted for medical and veterinary use; bacterial preparations for medical and veterinary use; probiotic bacteria preparations for medical use; foodstuffs and nutritional and food supplements featuring live or inactivated microorganisms, namely, nutritional supplements, enzyme food supplements, dietary food supplements, food supplements for humans and animals; ingredients based on inactive bacteria preparations and heattreated and heat-stabilized bacteria preparations, namely, Lactobacillus strains in combination with fermentation medium featured as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; ingredients based on combinations of inactivated and heat-treated Lactobacillus delbrueckii and Lactobacillus fermentum and fermentation medium sold as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; additives in the nature of dietary supplements for humans or for animals; ferments for medical or veterinary use with postbiotic or probiotic effects
N/A
N/A
Customized manufacture, for third parties, of pharmaceuticals, nutritional and food supplements featuring live or inactivated microorganisms; manufacture of ingredients comprising inactivated, heat-treated Lactobacillus strains and their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; custom manufacture, for third parties, of pharmaceutical and nutritional supplemental ingredients, namely, enriched culture medium and heat-treated microorganisms; manufacture of pharmaceutical ingredients, namely, heat-treated micro-organisms, for preparation of tablets, capsules, powders, injectable products, suspensions, liquids, for medical and veterinary use
N/A
N/A
No 79320342
No Service Mark
No 4662-4622
No
No
No
No
Yes
Yes
No
No
13.01.13 -
Electric lightbulbs, flashbulbs, fluorescent tubes
13.01.25 -
Other lighting equipment excluding ceiling fans with lights
26.01.21 -
Circles that are totally or partially shaded
26.03.14 -
Three or more ovals
26.03.28 -
Miscellaneous designs with overall oval shape, including amoeba-like shapes and irregular ovals
26.11.26 -
Oblongs as carriers for words, letters or designs
Status Date | Action Taken |
---|---|
15th Nov 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
19th Jul 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
04th Nov 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
06th Oct 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
06th Oct 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
06th Oct 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
20th Aug 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
02th Aug 2023 | FINAL DISPOSITION PROCESSED |
02th Aug 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
25th Jul 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |